Enzymatics
Codexis Licenses Life Science Enzyme Portfolio to Alphazyme
The agreement, which includes DNA polymerases, a reverse transcriptase, and other enzymes, will allow Codexis to focus more on its synthetic biology business.
EnPlusOne Biosciences, Wyss Institute Partner on Disease-Agnostic RNA Therapeutic Development
The project, part of a $27 million federally funded initiative, includes $3.5 million in funding to further develop EnPlusOne’s enzymatic RNA synthesis platform.
Wellcome Sanger Benchmarking Study Highlights Suitable Enzymes for NGS Library Amplification
Premium
The researchers evaluated over 20 high-fidelity polymerases for short-read and long-read applications, offering insights into their performances and pitfalls.
The Branford, Connecticut-based startup has launched products for cDNA synthesis leveraging its UltraMarathon reverse transcriptase.
The Chilean company said its enzymes, which are developed using its protein engineering platform and manufactured abroad, are cheaper than market alternatives.